Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from British American Tobacco ( (GB:BATS) ) is now available.
British American Tobacco has disclosed transactions involving James Murphy, Director of Research and Science, who transferred shares between his own accounts and to Kirsti Nordgard Murphy, a person closely associated with him. These transactions, involving a total of 9,532 ordinary shares, were conducted outside a trading venue on April 11, 2025, and were executed for nil consideration, indicating internal adjustments rather than market-driven sales.
Spark’s Take on GB:BATS Stock
According to Spark, TipRanks’ AI Analyst, GB:BATS is a Neutral.
British American Tobacco’s overall stock score reflects strong cash flow and dividend yield, appealing to income investors. The company’s financial performance is solid, yet earnings volatility and market challenges weigh on the assessment. Stable technical trends and a moderately attractive valuation, bolstered by strategic share buybacks, add support. However, the lack of strong momentum and external market challenges limit immediate upside potential.
To see Spark’s full report on GB:BATS stock, click here.
More about British American Tobacco
British American Tobacco p.l.c. operates within the tobacco industry, primarily focusing on the production and sale of cigarettes and other nicotine products. The company is a major player in the global market, with a diverse product portfolio aimed at satisfying various consumer preferences.
YTD Price Performance: 11.93%
Average Trading Volume: 5,396,820
Technical Sentiment Signal: Sell
Current Market Cap: £69.38B
For a thorough assessment of BATS stock, go to TipRanks’ Stock Analysis page.